跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Havrix 1440 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Havrix 1440
Approved
STANDARD
Havrix 1440
GlaxoSmithKline Philippines Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
94dfe2efc4a2c82e
Company
GlaxoSmithKline Philippines Inc.
Type
Standard
Approval Details
Approval Id
94dfe2efc4a2c82e
Drug Approval Philippines Name
Havrix 1440
Product Name
Havrix 1440
Registration Number
BR-1304
Brand Name
Havrix 1440
Generic Name
Hepatitis A (Inactivated) Vaccine (Adsorbed)
Dosage Form
Suspension for Injection (IM)
Dosage Strength
1440 ELISA units/mL
Manufacturer
GlaxoSmithKline Philippines Inc.
Importer
GlaxoSmithKline Philippines, Inc.
Issuance Date
24 January 2025
Expiry Date
24 January 2030
Pharmacologic Category
Vaccine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
94dfe2efc4a2c82e
Type
Standard
Back to Philippines FDA Approvals